title: Managing genomic and proteomic knowledge.
abstract: Genomic and proteomic platform data constitute a hugely important resource to current efforts in disease understanding, systems biology and drug discovery. We review prerequisites for the adequate management of 'omic' data, the means by which such data are analyzed and converted to knowledge relevant to drug discovery and issues crucial to the integration of such data, particularly with chemical, genetic and clinical data.:
authors: Bioinformatics Division, GlaxoSmithKline Pharmaceuticals, 709 Swedeland Road, P.O. Box 1539, King of Prussia, PA 19406, USA.
authors: Michael W
authors: MW
authors: Lutz
authors: Bioinformatics Division, GlaxoSmithKline Pharmaceuticals, 709 Swedeland Road, P.O. Box 1539, King of Prussia, PA 19406, USA.
authors: Patrick V
authors: PV
authors: Warren
authors: Bioinformatics Division, GlaxoSmithKline Pharmaceuticals, 709 Swedeland Road, P.O. Box 1539, King of Prussia, PA 19406, USA.
authors: Rob W
authors: RW
authors: Gill
authors: Bioinformatics Division, GlaxoSmithKline Pharmaceuticals, 709 Swedeland Road, P.O. Box 1539, King of Prussia, PA 19406, USA. Electronic address:David.B.Searls@gsk.com.
authors: David B
authors: DB
authors: Searls